OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 71 filers reported holding OCULAR THERAPEUTIX INC in Q3 2015. The put-call ratio across all filers is 1.76 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $402,000 | -13.2% | 65,000 | +30.0% | 0.01% | -15.4% |
Q2 2017 | $463,000 | -28.8% | 50,000 | -28.6% | 0.01% | -23.5% |
Q1 2017 | $650,000 | +10.9% | 70,000 | 0.0% | 0.02% | +6.2% |
Q4 2016 | $586,000 | +21.8% | 70,000 | 0.0% | 0.02% | +6.7% |
Q3 2016 | $481,000 | +39.0% | 70,000 | 0.0% | 0.02% | +36.4% |
Q2 2016 | $346,000 | -20.5% | 70,000 | +55.6% | 0.01% | -21.4% |
Q1 2016 | $435,000 | +3.1% | 45,000 | 0.0% | 0.01% | +27.3% |
Q4 2015 | $422,000 | +11.1% | 45,000 | +66.7% | 0.01% | +22.2% |
Q3 2015 | $380,000 | – | 27,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
Covestor Ltd | 60,008 | $316 | 0.28% |
Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |